Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase I-II Study of Preoperative Oxaliplatin-FU and Radiotherapy for Patients With Rectal Cancer

NCT00259363 is registered in ClinicalTrials.gov with Sanofi as lead sponsor.

NCT NCT00259363
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00259363 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase I-II Study of Preoperative Oxaliplatin-FU and Radiotherapy for Patients With Rectal Cancer
Lead sponsor
Sanofi
Phase
Phase 1/2
Overall status
Terminated
Start date
October 31, 2002
Completion date
Not reported
Enrollment
46 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

rectal neoplasms